KASINGER JAMES R. (General Counsel and Secretary) sold 3.1% of their position (2.80K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $147.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/12/2026ACC: 0001193125-26-104481
Officer· General Counsel and Secretary
Since Feb 2026
-2.80K
Net shares
Net seller
$147.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.50K acquired · 8.30K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+5.50K
Price / share
—
Trade value
—
% of position
6.5%
3/10/2026
85.11K→90.61K
Common Shares
Direct
Shares
−2.80K
Price / share
$52.80
Trade value
$147.84K
% of position
3.1%
3/11/2026
90.61K→87.81K
Total
Net shares
+2.70K
Net value
-$147.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/10/2026 | M · Option Exercise | +5.50K | — | — | 6.5% | 85.11K | 90.61K |
| Common Shares Direct | 3/11/2026 | S · Sale | −2.80K | $52.80 | $147.84K | 3.1% | 90.61K | 87.81K |
| Total | +2.70K | -$147.84K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
5.50K shares
Shares
−5.50K
Strike price
Held after
5.50K
Exercisable
—
3/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares5.50K shares | 3/10/2026 | M · Option Exercise | −5.50K | — | 5.50K |